| 摘要 |
<p>The present invention relates to compounds of Formula (I) that are useful for treating, preventing and/or managing the diseases, disorders, syndromes or conditions associated with the modulation of GPR119 receptor activity. The invention also relates to the process for preparation of the compounds, pharmaceutical compositions thereof. The invention further relates to methods of treating, preventing and/or managing diseases, disorders syndromes or conditions associated with the modulation of GPR119 receptor by using either alone or in combinations of Formula (I).</p> |
| 申请人 |
LUPIN LIMITED |
发明人 |
THOTAPALLY, RAJESH;KACHI, ONKAR, GANGARAM;RODGE, ATISH, HARISHCHANDRA;PATHAK, ASHOK, BHAU;KARDILE, BHAVANA, SHRIRANG;SINDKHEDKAR, MILIND, DATTATRAYA;PALLE, VENKATA, P.;KAMBOJ, RAJENDER, KUMAR |
